Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice

被引:23
作者
Mena, Guillermo [1 ,2 ]
Llupia, Anna [1 ,2 ]
Garcia-Basteiro, Alberto L. [1 ,2 ]
Diez, Consolacion [1 ,2 ]
Leon, Agathe [3 ]
Garcia, Felipe [3 ]
Bayas, Jose M. [1 ,2 ]
机构
[1] Hosp Clin Barcelona, Prevent Med & Epidemiol Unit, E-08036 Barcelona, Spain
[2] Hosp Clin Univ Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain
[3] Hosp Clin Barcelona, Infect Dis Unit, E-08036 Barcelona, Spain
关键词
Hepatitis B; HIV; Vaccination; Factors; Response; Rapidly accelerated schedule; IMMUNE-RESPONSE; INJECTIONS; SCHEDULE; EFFICACY; NUMBER; MEN; AGE;
D O I
10.1016/j.vaccine.2012.03.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B vaccination is recommended in HIV-infected patients. Achieving seroprotection rates (antiHBs >= 10 IU/L) comparable to the general population remains a challenge. The aim of this study was to analyze the proportion of responders among patients infected with HIV receiving primary HBV vaccination and identify factors associated with seroprotection rates. We analyzed the response to vaccination (antiHBs titers) in 474 HIV-infected patients receiving >= 1 doses of vaccine between 1994 and 2009. Factors associated with response to vaccination were analyzed using a logistic regression model. Considering the first vaccine courses administered, a response rate of 60.3% (286/474) was obtained. Eighty-seven patients began a second course, responding in 58.6% of cases. Regardless of the number of doses, schedules, and whether or not they completed the course, the response rates were 71.1% (337/474). After adjustment for year of reception of the first dose, responders were less likely to have a higher baseline HIV1-RNA viral load (OR: 0.78 95% CI: 0.68-0.91) and more likely to have a CD4 count >= 350 cells/mu L (OR: 1.64, 95% CI: 1.03-3.62). Patients receiving less than three doses of vaccine (OR: 0.31 95% CI 0.15-0.61) or three doses of the rapidly accelerated schedule (OR: 0.35 95% CI 0.15-0.81) had a lower probability of response in comparison with those receiving three doses of an accelerated schedule. In patients diagnosed with HIV, HBV vaccination before evolution to greater immunosuppression (CD4 <350 cells/mu L) or delaying vaccination until the CD4 count is higher could provide better seroprotection rates. The rapidly accelerated vaccination schedule should be used with caution, due to its lower effectiveness. If seroprotection is not achieved after the first course, revaccination seems to be effective in increasing the proportion of responders. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3703 / 3709
页数:7
相关论文
共 35 条
[1]  
[Anonymous], ENGERIX B GLAXOSMITH
[2]  
[Anonymous], TWINRIX ADULTOS GLAX
[3]  
Armstrong Kia E, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P179, DOI 10.1177/1545109710368721
[4]   Immunogenicity of hepatitis B vaccines - Implications for persons at occupational risk of hepatitis B virus infection [J].
Averhoff, F ;
Mahoney, F ;
Coleman, P ;
Schatz, G ;
Hurwitz, E ;
Margolis, H .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1998, 15 (01) :1-8
[5]   Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults [J].
Bailey, Christina L. ;
Smith, Vanessa ;
Sands, Michael .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (06) :E77-E83
[6]   HEPATITIS-B VACCINATION IN PRISONS - THE CATALONIAN EXPERIENCE [J].
BAYAS, JM ;
BRUGUERA, M ;
MARTIN, V ;
VIDAL, J ;
RODES, J ;
SALLERAS, LY .
VACCINE, 1993, 11 (14) :1441-1444
[7]   IMPAIRED RESPONSE TO RECOMBINANT HEPATITIS-B VACCINE IN HIV-INFECTED PERSONS [J].
BRUGUERA, M ;
CREMADES, M ;
SALINAS, R ;
COSTA, J ;
GRAU, M ;
SANS, J .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1992, 14 (01) :27-30
[8]   ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND SUBOPTIMAL RESPONSE TO HEPATITIS-B VACCINATION [J].
COLLIER, AC ;
COREY, L ;
MURPHY, VL ;
HANDSFIELD, HH .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (02) :101-105
[9]   Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients [J].
Cruciani, Mario ;
Mengoli, Carlo ;
Serpelloni, Giovanni ;
Lanza, Andrea ;
Gomma, Maurizio ;
Nardia, Stefano ;
Rimondo, Claudia ;
Bricolo, Francesco ;
Consolaro, Sandro ;
Trevisan, MariaTeresa ;
Bosco, Oliviero .
VACCINE, 2009, 27 (01) :17-22
[10]   The effect of age on immunologic response to recombinant hepatitis B vaccine: A meta-analysis [J].
Fisman, DN ;
Agrawal, D ;
Leder, K .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (11) :1368-1375